A report released by trade group Medicines for Europe has highlighted the inequitable and inconsistent access to essential medicines faced by countries across Central and Eastern Europe, noting that the full potential of off-patent medicines is not being reached across the region.
The organization says that “the root cause of these challenges is the policy framework in this region, with underinvestment in...




